| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.68B | 22.83B | 21.75B | 20.21B | 18.54B | 17.29B |
| Gross Profit | 4.73B | 4.55B | 4.36B | 4.03B | 3.56B | 3.22B |
| EBITDA | 2.27B | 2.04B | 1.83B | 1.57B | 1.33B | 958.61M |
| Net Income | 1.48B | 1.33B | 1.28B | 1.03B | 848.91M | 630.47M |
Balance Sheet | ||||||
| Total Assets | 14.82B | 15.07B | 13.65B | 12.72B | 11.36B | 10.78B |
| Cash, Cash Equivalents and Short-Term Investments | 6.08B | 6.46B | 5.81B | 5.18B | 4.89B | 4.55B |
| Total Debt | 315.00M | 340.00M | 200.00M | 260.00M | 230.00M | 70.00M |
| Total Liabilities | 4.53B | 5.01B | 4.84B | 5.23B | 5.10B | 5.22B |
| Stockholders Equity | 10.29B | 10.06B | 8.81B | 7.50B | 6.27B | 5.56B |
Cash Flow | ||||||
| Free Cash Flow | 319.02M | 829.76M | 1.13B | 1.03B | 0.00 | 814.60M |
| Operating Cash Flow | 319.02M | 838.18M | 1.15B | 1.04B | 0.00 | 951.28M |
| Investing Cash Flow | -4.40M | -30.71M | -18.03M | -462.69M | 71.16M | -218.85M |
| Financing Cash Flow | -157.33M | -146.00M | -448.77M | -313.62M | -90.05M | -189.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥29.37B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
74 Outperform | ¥29.01B | 35.99 | ― | ― | 29.61% | 93.16% | |
71 Outperform | ¥12.95B | 6.85 | ― | 2.93% | 9.83% | 12.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥13.17B | 46.76 | ― | ― | 6.24% | ― | |
57 Neutral | ¥14.32B | 15.26 | ― | 1.75% | 13.47% | 296.94% | |
55 Neutral | ¥32.28B | 29.01 | ― | ― | -10.49% | ― |